Adenoviral thymidine kinase prodrug gene therapy inhibits sarcoma growth in vivo

Journal of Surgical Research

Volumn 70, Issue 1, 1997, Pages 7-11

  Ross, Howard M ^a   Hirschowitz, Edward A ^a   Russi, Thomas J ^a   Crystal, Ronald G ^a   Nawata, Sumihiko ^a   Burt, Michael E ^a   Brennan, Murray F ^a   Lewis, Jonathan J ^a  

^a WEILL CORNELL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GANCICLOVIR; VIRUS VECTOR;

ADENOVIRUS; ANIMAL MODEL; ARTICLE; CANCER ADJUVANT THERAPY; CANCER GROWTH; CONTROLLED STUDY; GENE EXPRESSION; GENE THERAPY; GENE TRANSFER; HERPES SIMPLEX VIRUS; LATISSIMUS DORSI MUSCLE; NONHUMAN; PRIORITY JOURNAL; SARCOMA; VIRUS INFECTION;

EID: 0031171394     PISSN: 00224804     EISSN: None     Source Type: Journal    
DOI: 10.1006/jsre.1997.5113     Document Type: Article

References (14)

1. Jaques D. P., Coit D. G., Hadju S. I., Brennan M. F. Management of primary and recurrent soft-tissue sarcoma of the retroperitoneum. Ann. Surg. 212:1990;51.
2. J. J. Lewis, D. Leung, E. S. Casper, J. M. Woodruff, M. F. Brennan, 1996, The Association of Local Recurrence with Subsequent Survival in Extremity Soft Tissue Sarcoma.
3. Harrison L. B., Franzese F., Gaynor J. J., Brennan M. F. Long-term results of a prospective randomized trial of adjuvant brachytherapy in the management of completely resected soft tissue sarcomas of the extremity and superficial trunk. Int J. Radiat. Biol. Phys. 27:1993;259.
4. Sindelar W. F., Kinsella T. J., Chen P. W., DeLaney T. F., Tepper J. E., Rosenberg S. A., Glatstein E. Intraoperative radiotherapy in retroperitoneal sarcomas. Arch. Surg. 128:1993;402.
5. Hwang H. C., Smythe W. R., Elshami A. A., Kucharczuk J. C., Amin K. M., Williams J. P., Litsky L. A., Kaiser L. R., Albeda S. M. Gene therapy using adenovirus carrying the herpes simplex-thymidine kinase gene to treat in vivo models of human malignant mesothelioma and lung cancer. Am. J. Respir. Cell Mol. Biol. 13:1995;7.
6. Chen S., Shine H. D., Goodman J. C., Grossman R. G., Woo S. L. C. Gene therapy for brain tumors: Regression of experimental gliomas by adenovirus-mediated gene transfer in vivo. Proc. Natl. Acad. Sci. USA. 91:1994;3054.
7. Clayman G. L., El-Naggar A. K., Roth J. A., Zhang W., Goepfert H., Taylor D. L., Liu T. In vivo molecular therapy with p53 adenovirus for microscopic residual head and neck squamous carcinoma. Cancer Res. 55:1995;1.
8. Yang Y., Li Q., Ertl H. C., Wilson J. M. Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses. J. Virol. 69:1995;2004.
9. Moolten F. L. Tumor chemosensitivity conferred by inserted herpes thymidine kinase genes: Paradigm for a prospective cancer control strategy. Cancer Res. 46:1986;5276.
10. Matthews T., Boehme R. Antiviral activity and mechanism of action of ganciclovir. Rev. Infect. Dis. 10:1988;490.
11. Freeman S. M., Abboud C. N., Whartenby K. A., Packman C. H., Koeplin D. S., Moolten F. L., Abraham G. N. The "bystander effect": Tumor regression when a fraction of the tumor mass is genetically modified. Cancer Res. 53:1993;5274.
12. Guzman R. J., Hirschowitz E. A., Brody S. L., Crystal R. G., Epstein S. E., Finkel T. In vivo suppression of injury-induced vascular smooth muscle cell accumulation using adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene. Proc. Natl. Acad. Sci. USA. 91:1994;10732.
13. Hirschowitz E. A., Ohwada A., Pascal W. R., Russi T. J., Crystal R. G. In vivoEscherichia coli. Hum. Gene Ther. 6:1995;1055.
14. Folkman J. The role of angiogenesis in tumor growth. Semin. Cancer Biol. 3:1992;65.